Lichen International Limited
LICN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $41 | $40 | $34 | $34 |
| % Growth | 4.3% | 17.6% | -1.4% | – |
| Cost of Goods Sold | $16 | $15 | $14 | $14 |
| Gross Profit | $26 | $24 | $20 | $20 |
| % Margin | 61.9% | 61.2% | 59.7% | 59.7% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $18 | $9 | $7 | $7 |
| SG&A Expenses | $30 | $12 | $10 | $9 |
| Sales & Mktg Exp. | $13 | $3 | $2 | $2 |
| Other Operating Expenses | -$1 | -$1 | -$1 | -$1 |
| Operating Expenses | $30 | $12 | $10 | $9 |
| Operating Income | -$5 | $12 | $11 | $11 |
| % Margin | -11% | 30.8% | 31.5% | 32.9% |
| Other Income/Exp. Net | $0 | -$1 | $0 | $0 |
| Pre-Tax Income | -$4 | $12 | $11 | $12 |
| Tax Expense | $2 | $3 | $3 | $3 |
| Net Income | -$6 | $8 | $8 | $8 |
| % Margin | -14.8% | 21% | 23.1% | 24.7% |
| EPS | -0.41 | 63.96 | 69.49 | 0.29 |
| % Growth | -100.6% | -8% | 23,862.1% | – |
| EPS Diluted | -0.41 | 63.96 | 69.49 | 0.29 |
| Weighted Avg Shares Out | 15 | 27 | 23 | 29 |
| Weighted Avg Shares Out Dil | 15 | 27 | 23 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $1 | $1 | $2 |
| EBITDA | -$2 | $13 | $11 | $14 |
| % Margin | -4% | 32.7% | 33.6% | 40.1% |